scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1022880510 |
P356 | DOI | 10.1038/BJC.1998.329 |
P932 | PMC publication ID | 2150365 |
P698 | PubMed publication ID | 9667679 |
P5875 | ResearchGate publication ID | 13616618 |
P2093 | author name string | Yen SH | |
Chen KY | |||
Wu CW | |||
Lee SD | |||
Chen SY | |||
Chao Y | |||
Lo SS | |||
Lui WY | |||
Chan WK | |||
Chi KH | |||
P2860 | cites work | cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice | Q28284338 |
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer | Q33363249 | ||
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou | Q33388301 | ||
High-dose MTX/5-FU and adriamycin for gastric cancer. | Q33479823 | ||
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). | Q33491452 | ||
Chemotherapy of gastric cancer | Q38648447 | ||
Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies | Q39650657 | ||
Gastric carcinoma. A ten-year review | Q40272009 | ||
Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy | Q40527919 | ||
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report | Q40677653 | ||
The treatment of advanced gastric cancer | Q40938936 | ||
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research | Q41009660 | ||
Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism | Q41760435 | ||
New developments in the treatment of gastric carcinoma | Q41872774 | ||
Optimal two-stage designs for phase II clinical trials | Q46412217 | ||
Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells | Q46436559 | ||
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. | Q51136983 | ||
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. | Q53647935 | ||
Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer. | Q54192267 | ||
Adjuvant and neoadjuvant therapy for gastric cancer | Q57217644 | ||
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer | Q70753009 | ||
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group study | Q71067311 | ||
Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma | Q71088888 | ||
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group | Q72256279 | ||
A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma | Q72736677 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cisplatin | Q412415 |
etoposide | Q418817 | ||
fluorouracil | Q238512 | ||
P304 | page(s) | 1984-1988 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer | |
P478 | volume | 77 |
Q44180988 | A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer |
Q35097713 | Curative treatment of gastric cancer: towards a multidisciplinary approach? |
Q78766414 | Gastric adenocarcinoma with Sister Mary Joseph's nodule successfully treated with combined chemoradiation |
Q33361500 | Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. |
Q34385364 | Recent advances in the treatment of gastric cancer |